Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

EMILY RUIZ

Allopathic & Osteopathic Physicians Dermatology

NPI
1053638197
CMS profile
2677893
Location
BOSTON, MA

General Payments · PY2018–2024

$68,095.47

  • Reported across 51 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$31,147.31

28 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $412.44 2
PY2019 $4,098.67 7
PY2020 $24,322.00 5
PY2021 $3,640.00 2
PY2022 $3,097.10 5
PY2023 $1,377.95 2
PY2024 $31,147.31 28

Payment records · PY2024 (28)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Integra LifeSciences Corporation $146.68 08/05/2024 Long term medical supply or device loan Undisputed 01/23/2026 1140094022 CMS
Integra LifeSciences Corporation $132.55 08/21/2024 Long term medical supply or device loan Undisputed 01/23/2026 1140094027 CMS
Merck Sharp & Dohme LLC $915.00 06/19/2024 Consulting Fee Undisputed 01/23/2026 1141590300 CMS
Regeneron Healthcare Solutions, Inc. $96.67 01/23/2024 Food and Beverage Undisputed 01/23/2026 1114151034 CMS
Regeneron Healthcare Solutions, Inc. $706.44 10/31/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1114151036 CMS
Regeneron Healthcare Solutions, Inc. $121.00 12/17/2024 Food and Beverage Undisputed 01/23/2026 1114151038 CMS
Regeneron Healthcare Solutions, Inc. $4,872.00 12/17/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1114151040 CMS
Regeneron Pharmaceuticals, Inc. $4,949.20 02/27/2024 Travel and Lodging Undisputed 01/23/2026 1114404347 CMS
Regeneron Pharmaceuticals, Inc. $35.25 02/29/2024 Travel and Lodging Undisputed 01/23/2026 1114404349 CMS
Regeneron Pharmaceuticals, Inc. $20.84 03/14/2024 Food and Beverage Undisputed 01/23/2026 1114404351 CMS
Regeneron Pharmaceuticals, Inc. $141.45 03/14/2024 Food and Beverage Undisputed 01/23/2026 1114404353 CMS
Regeneron Pharmaceuticals, Inc. $135.85 03/14/2024 Food and Beverage Undisputed 01/23/2026 1114404355 CMS
Regeneron Pharmaceuticals, Inc. $124.85 04/03/2024 Travel and Lodging Undisputed 01/23/2026 1114404357 CMS
Regeneron Pharmaceuticals, Inc. $124.85 04/08/2024 Travel and Lodging Undisputed 01/23/2026 1114404359 CMS
Regeneron Pharmaceuticals, Inc. $812.00 04/26/2024 Consulting Fee Undisputed 01/23/2026 1114404361 CMS
Regeneron Pharmaceuticals, Inc. $4,872.00 04/26/2024 Consulting Fee Undisputed 01/23/2026 1114404363 CMS
Regeneron Pharmaceuticals, Inc. $406.00 06/07/2024 Consulting Fee Undisputed 01/23/2026 1114404365 CMS
Regeneron Pharmaceuticals, Inc. $812.00 06/07/2024 Consulting Fee Undisputed 01/23/2026 1114404367 CMS
Regeneron Pharmaceuticals, Inc. $406.00 06/07/2024 Consulting Fee Undisputed 01/23/2026 1114404369 CMS
Regeneron Pharmaceuticals, Inc. $4,872.00 06/07/2024 Consulting Fee Undisputed 01/23/2026 1114404371 CMS
Regeneron Pharmaceuticals, Inc. $1,624.00 06/07/2024 Consulting Fee Undisputed 01/23/2026 1114404373 CMS
Regeneron Pharmaceuticals, Inc. $343.98 06/07/2024 Travel and Lodging Undisputed 01/23/2026 1114404375 CMS
Regeneron Pharmaceuticals, Inc. $345.51 06/07/2024 Travel and Lodging Undisputed 01/23/2026 1114404377 CMS
Regeneron Pharmaceuticals, Inc. $347.19 06/07/2024 Travel and Lodging Undisputed 01/23/2026 1114404379 CMS
Regeneron Pharmaceuticals, Inc. $236.50 10/25/2024 Consulting Fee Undisputed 01/23/2026 1114404381 CMS
Regeneron Pharmaceuticals, Inc. $827.75 10/25/2024 Consulting Fee Undisputed 01/23/2026 1114404383 CMS
Regeneron Pharmaceuticals, Inc. $2,010.25 10/25/2024 Consulting Fee Undisputed 01/23/2026 1114404385 CMS
Regeneron Pharmaceuticals, Inc. $709.50 10/25/2024 Consulting Fee Undisputed 01/23/2026 1114404387 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.